左氧氟沙星
医学
生物等效性
质量(理念)
风险分析(工程)
活性成分
溶解试验
药理学
产品(数学)
药品
生物利用度
业务
重症监护医学
抗生素
化学
生物化学
哲学
生物制药分类系统
几何学
数学
认识论
作者
Ensieh Izadi,Gull Afshan,Rahul P. Patel,Venkatesan Moorthy Rao,Kai Bin Liew,Meor Mohd Redzuan Meor Mohd Affandi,Nurolaini Kifli,Amal K. Suleiman,Kah Seng Lee,Md. Moklesur Rahman Sarker,Syed Tabish R. Zaidi,Long Chiau Ming
标识
DOI:10.3389/fphar.2019.00881
摘要
Counterfeit and substandard medicines are recognized as one of serious threats to public health. The product quality of antibacterial medicine will compromise patients' recovery and increase the chance of antibacterial resistance. The review aims to provide a summary of low quality levofloxacin issues and the risk factors as well as suggesting the aspects of product quality that need to be regulated strictly. Quality of the active ingredient, levofloxacin has an important role to contribute to successful therapy. The poor quality of raw material, directly and indirectly, causes treatment failure as the presence of insufficient dose, mislabeled content and poor dissolution characteristics can lead to lower bioavailability. Identifying and reporting these factors can potentially help in improving the quality of drug marketed in various developing countries and may also reduce the incidences of treatment failure. Dissolution test is used for testing the dissolution profiles and the rate of drug release from solid formulation such as oral formulations, thus providing information regarding the in vivo performance of a formulation and its bioequivalence. On the other hand, quality testing procedures are used for comparing the quality of products.
科研通智能强力驱动
Strongly Powered by AbleSci AI